# Docetaxel and S-1 for Advanced Esophageal Cancer

> **NCT01693432** · PHASE2 · UNKNOWN · sponsor: **Hallym University Medical Center** · enrollment: 37 (estimated)

## Conditions studied

- Esophageal Neoplasms

## Interventions

- **DRUG:** DS (docetaxel+S-1)

## Key facts

- **NCT ID:** NCT01693432
- **Lead sponsor:** Hallym University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-11
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2017-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01693432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01693432, "Docetaxel and S-1 for Advanced Esophageal Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01693432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*